Global Nerve Repair and Regeneration Market is expected to grow at a lucrative rate of ~12% by 2027 : Growing Cases of Nerve Injuries
26 avr. 2023 12h20 HE
|
Medi-Tech Insights
BRUSSELS, BELGIUM, April 26, 2023 (GLOBE NEWSWIRE) -- Repair and regeneration in the nervous system is a process by which damaged tissue undergoes regrowth or renewal, eventually restoring nervous...
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
25 avr. 2023 10h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
ONWARD erhält weitere FDA Breakthrough Device Designations für Blasenkontrolle, Linderung von Spastiken und Blutdruckregulation nach Rückenmarksverletzung
23 févr. 2023 01h30 HE
|
ONWARD Medical
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD reçoit de nouvelles désignations de dispositifs révolutionnaires de la FDA pour le contrôle de la vessie, le soulagement de la spasticité et la régulation de la pression artérielle après une lésion de la moelle épinière
23 févr. 2023 01h30 HE
|
ONWARD Medical
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 23 févr. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext : ONWD), société de technologie médicale créant des thérapies...
ONWARD ontvangt nieuwe FDA Breakthrough Device Designations voor blaascontrole, vermindering van spasticiteit en bloeddrukregeling bij dwarslaesiepatiënten
23 févr. 2023 01h30 HE
|
ONWARD Medical
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), ONWARD Medical N.V. (Euronext: ONWD), het medische...
ONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury
23 févr. 2023 01h30 HE
|
ONWARD Medical
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative...
Neurotech Devices Global Market Outlook Report 2023: Market Revenue Data for 2021, Estimates for 2022, 2023, 2025, and CAGR Projections through 2027
14 févr. 2023 09h38 HE
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based...
Global Intraoperative Neuromonitoring (IONM) Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
19 janv. 2023 04h58 HE
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer’s Disease
25 oct. 2022 07h15 HE
|
Sinaptica Therapeutics
Phase II sham-controlled randomized trial met its primary endpoint with statistical significance; treatment slowed cognitive decline by 82% over 6 months in the treated population compared to sham...
The Worldwide Neurostimulation Devices Industry is Expected to Reach $17.3 Billion by 2030
22 août 2022 06h23 HE
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Neurostimulation Devices Market, by Device Type, by Application, by End-user, Estimation & Forecast, 2017-2030" report has been added to...